Related Experiment Video

Updated: Jan 15, 2026

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
10:36

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Published on: June 20, 2017

9.0K

Plasma platelet-derived growth factor receptor-β decrease correlates with blood-brain barrier damage in Alzheimer's

Jieyin Li1,2, Anqi Li1,3, Chenghui Ye4

  • 1Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen, 518132, China.

Molecular Neurodegeneration
|January 14, 2026
PubMed
Summary

No abstract available in PubMed .

Keywords:
Alzheimer’s diseaseBBBPlasma PDGFRβQalb

More Related Videos

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
07:22

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

Published on: November 8, 2017

10.5K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.8K

Related Experiment Videos

Last Updated: Jan 15, 2026

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
10:36

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Published on: June 20, 2017

9.0K
Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
07:22

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

Published on: November 8, 2017

10.5K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.8K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

52.3K
Overview
52.3K

Articles linked to this work by shared authors, journal, and citation graph.

Ovarian Metastasis from Invasive Lobular Carcinoma of the Breast: A 6-Case Series with Emphasis on Diagnostic Challenges and the Value of Biopsy.

Diagnostics (Basel, Switzerland)·2026

The value of non-enhanced magnetic resonance imaging based on T2-weighted imaging and apparent diffusion coefficient in the study of three-tiered HER2 status in patients with breast cancer.

Quantitative imaging in medicine and surgery·2026

A generative adversarial network model for improved three-dimensional mapping of pulmonary arteries and veins from non-contrast computed tomography in sublobar resection planning.

Quantitative imaging in medicine and surgery·2026

Construction of selenium nanoparticles for the transmembrane absorption of Polygonatum Sibiricum polysaccharides and their antioxidant activity.

RSC advances·2026

Bone-related adverse events of hormonal therapy: A pharmacovigilance study based on the Food & Drug Administration Adverse Event Reporting System.

The Journal of international medical research·2026

The miR156h-TaSPL4-TaPIN18 Module Regulates Plant Architecture and Grain Size by Modulating Auxin Transport in Wheat.

Plant, cell & environment·2026

Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes.

Molecular neurodegeneration·2026

Breaking the glial loop: astrocytic PAD2 and citrullinated vimentin drive microglial dysfunction in Alzheimer's disease.

Molecular neurodegeneration·2026

Understanding the genetic imperfections of Lewy body dementia.

Molecular neurodegeneration·2026

ApoE lipoproteins in the central nervous system under homeostasis and role in Alzheimer's disease and related disorders.

Molecular neurodegeneration·2026

The human LRRK2-R1441G mutation drives age-dependent oxidative stress and mitochondrial dysfunction in dopaminergic neurons.

Molecular neurodegeneration·2026

TDP-43 dysfunction facilitates the pathological conversion of tau.

Molecular neurodegeneration·2026

Interrogating roles for VTA dopamine neurons in locomotion and ultrasonic vocalizations elicited by different classes of rewarding drugs.

Psychopharmacology·2026

Transcriptional Response to Chronic Long-Access Fentanyl Self-Administration in Rat Habenula and Amygdala.

Addiction biology·2026

Shank3b deficiency drives anxiety-like behaviors via impaired GABAergic inhibition and enhanced intrinsic excitability in the basolateral amygdala.

Neuropharmacology·2026

Evaluation of Bronchial Receptors with Concentration-Response Curves, Bitterness Assessment, and Computer Simulations.

Cell biochemistry and biophysics·2026

Lead (Pb) and the NMDA Receptor Hypofunction Hypothesis: A Comparative Review of Non-Essential Metal Exposures in Schizophrenia.

Current environmental health reports·2026

Open-label placebo effects on psychological distress and hair cortisol in a randomized controlled trial - the moderating role of the five-factor personality traits.

Comprehensive psychoneuroendocrinology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us